These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Efficacy and safety of switching from topical latanoprost to bimatoprost in patients with normal-tension glaucoma. Sato S, Hirooka K, Baba T, Mizote M, Fujimura T, Tenkumo K, Ueda H, Shiraga F. J Ocul Pharmacol Ther; 2011 Oct; 27(5):499-502. PubMed ID: 21790301 [Abstract] [Full Text] [Related]
10. Prostaglandin efficacy and safety study undertaken by race (the PRESSURE study). Birt CM, Buys YM, Ahmed II, Trope GE, Toronto Area Glaucoma Society. J Glaucoma; 2010 Sep; 19(7):460-7. PubMed ID: 20051890 [Abstract] [Full Text] [Related]
11. Latanoprost therapy after sunken eyes caused by travoprost or bimatoprost. Nakakura S, Tabuchi H, Kiuchi Y. Optom Vis Sci; 2011 Sep; 88(9):1140-4. PubMed ID: 21666524 [Abstract] [Full Text] [Related]
14. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%. Maul E, Carrasco FG, Costa VP, Casiraghi JF, Vargas E, Sarmina JS, Mayol R. Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191 [Abstract] [Full Text] [Related]